LDN Social Media
Get connected with us on social networks
Spike Protein Disrupting Immunity in Millions After COVID Infection or Vaccination
The SARS-CoV-2 spike protein is a highly toxic and inflammatory protein, capable of causing pathologies in its hosts, and has been strongly linked with long COVID and post-vaccine symptoms. Spike proteins are often present in symptomatic patients, sometimes even months after infections or vaccinations. The immune dysfunction caused by spike protein not only causes inflammation, but also may also contribute to cancer proliferation, and autoimmunity.
Spike proteins can reduce and exhaust the action of T and natural killer cells responsible for killing infected cells and cancerous cells. Therefore a reduced cellular immunity from T and natural killer cells can contribute to an untimely clearance of spike-infected cells. Damage from spike proteins can lead to damaged DNA, and studies have shown that spike proteins can also reduce DNA repair.
The first line treatments recommended by the Front Line COVID-19 Critical Care Alliance (FLCCC) focus on two main steps. The first step is to remove spike protein, the second step is to reduce its toxicity. Discussed are various therapeutic approaches including low dose naltrexone (LDN). FLCCC doctors have seen many of their patients’ symptoms improve following treatment with LDN, though it may take months for the benefits to be clearly visible. This is because LDN also reduces neuroinflammation. It is neuroprotective and is able to cross the blood-brain barrier and reduce inflammatory actions of the microglia, which function as immune cells in the brain.